1. Home
  2. ISPC vs TCRT Comparison

ISPC vs TCRT Comparison

Compare ISPC & TCRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo iSpecimen Inc.

ISPC

iSpecimen Inc.

HOLD

Current Price

$1.49

Market Cap

4.0M

Sector

Health Care

ML Signal

HOLD

Logo Alaunos Therapeutics Inc.

TCRT

Alaunos Therapeutics Inc.

HOLD

Current Price

$1.52

Market Cap

4.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ISPC
TCRT
Founded
2009
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Precision Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.0M
4.2M
IPO Year
2020
2025

Fundamental Metrics

Financial Performance
Metric
ISPC
TCRT
Price
$1.49
$1.52
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
474.3K
11.8K
Earning Date
05-18-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
87.03
24.66
EPS
N/A
N/A
Revenue
$1,928,998.00
$15,900,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.10
$1.50
52 Week High
$6.77
$4.57

Technical Indicators

Market Signals
Indicator
ISPC
TCRT
Relative Strength Index (RSI) 31.96 27.79
Support Level $1.40 N/A
Resistance Level $2.38 $2.03
Average True Range (ATR) 0.12 0.09
MACD 0.00 -0.01
Stochastic Oscillator 12.50 9.69

Price Performance

Historical Comparison
ISPC
TCRT

About ISPC iSpecimen Inc.

iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas, Europe, the Middle East, Africa, and the Asia Pacific, with the majority coming from the Americas. The Company has one reportable segment: biospecimens.

About TCRT Alaunos Therapeutics Inc.

Alaunos Therapeutics Inc is a preclinical-stage biopharmaceutical company focused on the development of novel, orally administered small-molecule therapeutics for obesity and related metabolic disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD, a type of fatty liver disease). The program aims to develop a differentiated, non-hormonal, non-incretin approach, unlike hormone-based treatments like GLP-1 drugs. It has a single reportable and operating segment related to biopharmaceutical research and development.

Share on Social Networks: